• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血小板输注可诱导对D及非D恒河猴抗原产生同种免疫。

Platelet Transfusion Induces Alloimmunization to D and Non-D Rhesus Antigens.

作者信息

Reckhaus Johanna, Jutzi Markus, Fontana Stefano, Bacher Vera Ulrike, Vogt Marco, Daslakis Michael, Mansouri Taleghani Behrouz

机构信息

University Department of Hematology, Inselspital, University of Bern, Bern, Switzerland.

Interregional Blood Transfusion Swiss Red Cross, Bern, Switzerland.

出版信息

Transfus Med Hemother. 2018 May;45(3):167-172. doi: 10.1159/000490122. Epub 2018 May 24.

DOI:10.1159/000490122
PMID:29928171
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6006606/
Abstract

BACKGROUND

Platelet concentrates (PC) contain residual contaminating red blood cells (RBC), being higher in pooled buffy coat PC (BC-PC) than in apheresis units (AP-PC). Data about PC-induced alloimmunization against non-D Rhesus (Rh) antigens are limited.

METHODS

For all newly detected RhD and non-D alloantibodies between August 2015 and September /2017 we prospectively evaluated if they were triggered through PC by analyzing for incompatible RBC and/or PC transfusions.

RESULTS

We found 5,799 positive results in 89,190 antibody screening tests. We identified 13 newly detectable Rh antibodies through incompatible PCs in 11 patients: 6× anti-D, 4× anti-E, 2× anti-c, 1× anti-f. They received a total of 156 PC (83 BC-PC; 73 AP-PC): 5 patients received incompatible BC-PC only, 1 patient received incompatible AP-PC only, 5 patients received incompatible BC-PC and AP-PC. Quality control showed a mean (range) of 0.304 (0.152-1.662) and 0.014 (0.003-0.080) × 10 RBC/l for BC-PC and AP-PC, respectively. Ten of the 11 patients received RBC transfusions, all of them being antigen-negative for the alloantibodies identified.

CONCLUSIONS

PC transfusions may not only induce RhD alloimmunization, but also immunization against further Rh antigens such as c, E, and f. The risk seems higher for BC-PC than for AP-PC. The results may have impact on future recommendations of PC transfusion with respect to Rh compatibility and upper limits of RBC contamination.

摘要

背景

血小板浓缩物(PC)含有残留的污染红细胞(RBC),在混合富血小板血浆PC(BC-PC)中的含量高于单采血小板单位(AP-PC)。关于PC诱导的针对非D型恒河猴(Rh)抗原的同种免疫的数据有限。

方法

对于2015年8月至2017年9月期间所有新检测到的RhD和非D型同种抗体,我们通过分析不相容的RBC和/或PC输血情况,前瞻性评估它们是否由PC引发。

结果

在89,190次抗体筛查试验中,我们发现了5,799个阳性结果。我们在11例患者中通过不相容的PC鉴定出13种新可检测到的Rh抗体:6例抗-D、4例抗-E、2例抗-c、1例抗-f。他们共接受了156个PC(83个BC-PC;73个AP-PC):5例患者仅接受了不相容的BC-PC,1例患者仅接受了不相容的AP-PC,5例患者接受了不相容的BC-PC和AP-PC。质量控制显示,BC-PC和AP-PC的RBC含量平均(范围)分别为0.304(0.152 - 1.662)和0.014(0.003 - 0.080)×10⁹/L。11例患者中有10例接受了RBC输血,所有患者对鉴定出的同种抗体均为抗原阴性。

结论

PC输血不仅可能诱导RhD同种免疫,还可能诱导针对其他Rh抗原(如c、E和f) 的免疫。BC-PC的风险似乎高于AP-PC。这些结果可能会对未来关于PC输血在Rh相容性和RBC污染上限方面的建议产生影响。

相似文献

1
Platelet Transfusion Induces Alloimmunization to D and Non-D Rhesus Antigens.血小板输注可诱导对D及非D恒河猴抗原产生同种免疫。
Transfus Med Hemother. 2018 May;45(3):167-172. doi: 10.1159/000490122. Epub 2018 May 24.
2
Rhesus D Antigenic Determinants on Residual Red Blood Cells in Apheresis and Buffy Coat Platelet Concentrates.单采血小板和富血小板血浆中残余红细胞上的恒河猴D抗原决定簇
Transfus Med Hemother. 2020 Apr;47(2):129-134. doi: 10.1159/000501106. Epub 2019 Jun 27.
3
Anti-D Alloimmunization Following Rhesus-Incompatible Platelet Transfusion in a Myelodysplastic Syndrome Patient.一名骨髓增生异常综合征患者接受恒河猴血型不相容血小板输注后的抗-D同种免疫
Cureus. 2024 Mar 29;16(3):e57165. doi: 10.7759/cureus.57165. eCollection 2024 Mar.
4
Absence of anti-D alloimmunization in hematologic patients after D-incompatible platelet transfusions.D 血型不相容的血小板输注后血液学患者中抗 D 同种免疫的缺失
Transfusion. 2002 Feb;42(2):173-6. doi: 10.1046/j.1537-2995.2002.00038.x.
5
Quality assessment of platelet concentrates prepared by platelet-rich plasma, buffy-coat, and apheresis methods in a tertiary care hospital in South India: A cross-sectional study.印度南部一家三级护理医院中通过富血小板血浆、血沉棕黄层和单采法制备的血小板浓缩物的质量评估:一项横断面研究。
Asian J Transfus Sci. 2023 Jul-Dec;17(2):239-245. doi: 10.4103/ajts.ajts_73_22. Epub 2022 Dec 12.
6
Transfusion of RhD-incompatible blood components in RhD-negative blood marrow transplant recipients.RhD阴性造血干细胞移植受者输注RhD不相合血液成分
MedGenMed. 2004 Jul 13;6(3):22.
7
Anti-E alloimmunization from a platelet apheresis transfusion in a 22-month-old male with acute myeloid leukemia.22 个月大的男性急性髓系白血病患者,行血小板单采术输血后产生抗-E 同种免疫。
Lab Med. 2024 Jul 3;55(4):517-519. doi: 10.1093/labmed/lmae002.
8
Transfusion of platelet concentrates--clinical evaluation of two preparations.浓缩血小板输注——两种制剂的临床评估
Eur J Haematol. 1996 Oct;57(4):307-11. doi: 10.1111/j.1600-0609.1996.tb01382.x.
9
Immune erythrocyte antibodies in adult patients with sickle cell disease and blood donors in Lagos, Nigeria: a comparative study.尼日利亚拉各斯地区镰状细胞病成年患者和献血者中的免疫性红细胞抗体:一项对比研究。
Immunohematology. 2021 Sep;37(3):131-137. doi: 10.21307/immunohematology-2021-020.
10
Cancer type predicts alloimmunization following RhD-incompatible RBC transfusions.癌症类型可预测RhD血型不相容的红细胞输血后的同种免疫反应。
Transfusion. 2017 Apr;57(4):952-958. doi: 10.1111/trf.13999. Epub 2017 Feb 12.

引用本文的文献

1
Megakaryopoiesis impairment through acute innate immune signaling activation by azacitidine.阿扎胞苷通过急性先天免疫信号激活导致巨核细胞生成受损。
J Exp Med. 2022 Nov 7;219(11). doi: 10.1084/jem.20212228. Epub 2022 Sep 2.
2
Does ABO and RhD matching matter for platelet transfusion?ABO 和 RhD 配型对血小板输注重要吗?
Hematology Am Soc Hematol Educ Program. 2020 Dec 4;2020(1):512-517. doi: 10.1182/hematology.2020000135.
3
Residual red cells in blood components: A multisite study of fully automated enumeration using a hematology analyzer.血液成分中的残留红细胞:使用血液分析仪进行全自动计数的多站点研究。
Transfusion. 2021 Feb;61(2):568-578. doi: 10.1111/trf.16196. Epub 2020 Nov 17.
4
Pathogen-reduced PRP blocks T-cell activation, induces Treg cells, and promotes TGF-β expression by cDCs and monocytes in mice.减菌 PRP 通过小鼠树突状细胞和单核细胞抑制 T 细胞激活,诱导 Treg 细胞,并促进 TGF-β 表达。
Blood Adv. 2020 Nov 10;4(21):5547-5561. doi: 10.1182/bloodadvances.2020002867.
5
Non-RhD (anti-E) red cell alloimmunization following platelet transfusion: a case report and implications on quality of the platelet concentrates and antibody screening protocols.血小板输注后非RhD(抗-E)红细胞同种免疫:一例报告及对血小板浓缩物质量和抗体筛查方案的启示
Hematol Transfus Cell Ther. 2022 Apr-Jun;44(2):272-274. doi: 10.1016/j.htct.2020.08.009. Epub 2020 Sep 13.
6
Rhesus D Antigenic Determinants on Residual Red Blood Cells in Apheresis and Buffy Coat Platelet Concentrates.单采血小板和富血小板血浆中残余红细胞上的恒河猴D抗原决定簇
Transfus Med Hemother. 2020 Apr;47(2):129-134. doi: 10.1159/000501106. Epub 2019 Jun 27.
7
Seroconversion of red blood cell antibody in ABO-incompatible living donor liver transplantation -a case report.ABO 血型不相容活体肝移植中红细胞抗体的血清学转换:1 例报告。
Korean J Anesthesiol. 2020 Jun;73(3):252-256. doi: 10.4097/kja.19141. Epub 2019 Jul 15.
8
Hemovigilance.血液警戒
Transfus Med Hemother. 2018 May;45(3):148-150. doi: 10.1159/000490075. Epub 2018 May 24.

本文引用的文献

1
Red blood cell alloimmunization: new findings at the bench and new recommendations for the bedside.红细胞同种免疫:实验室的新发现及床边的新建议。
Curr Opin Hematol. 2016 Nov;23(6):543-549. doi: 10.1097/MOH.0000000000000277.
2
I am the 9%: Making the case for whole-blood platelets.我是那9%:支持全血血小板的理由
Transfus Med. 2016 Jun;26(3):177-85. doi: 10.1111/tme.12312. Epub 2016 May 12.
3
Incidence of alloantibody formation after ABO-D or extended matched red blood cell transfusions: a randomized trial (MATCH study).ABO-D 或扩展匹配红细胞输血后同种抗体形成的发生率:一项随机试验(MATCH 研究)。
Transfusion. 2016 Feb;56(2):311-20. doi: 10.1111/trf.13347. Epub 2015 Oct 7.
4
Platelet transfusion and respecting patient D type.血小板输注与尊重患者的D型(此处D type含义不明,可能需要结合更多背景信息准确理解)
Curr Opin Hematol. 2015 Nov;22(6):540-6. doi: 10.1097/MOH.0000000000000185.
5
Easier said than done: ABO compatibility and D matching in apheresis platelet transfusions.说起来容易做起来难:单采血小板输注中的ABO血型相容性和D抗原匹配
Transfusion. 2015 Aug;55(8):1882-8. doi: 10.1111/trf.13077. Epub 2015 Mar 11.
6
Prospective surveillance of D- recipients of D+ apheresis platelets: alloimmunization against D is not detected.对接受D+单采血小板的D-受者进行前瞻性监测:未检测到针对D的同种免疫。
Transfusion. 2015 Jun;55(6):1327-30. doi: 10.1111/trf.12972. Epub 2014 Dec 19.
7
Low frequency of anti-D alloimmunization following D+ platelet transfusion: the Anti-D Alloimmunization after D-incompatible Platelet Transfusions (ADAPT) study.D+血小板输注后抗-D 同种免疫的发生率较低:D 不相容血小板输注后抗-D 同种免疫(ADAPT)研究。
Br J Haematol. 2015 Feb;168(4):598-603. doi: 10.1111/bjh.13158. Epub 2014 Oct 4.
8
The clinical and biological impact of new pathogen inactivation technologies on platelet concentrates.新型病原体灭活技术对血小板浓缩物的临床和生物学影响。
Blood Rev. 2014 Nov;28(6):235-41. doi: 10.1016/j.blre.2014.07.005. Epub 2014 Aug 24.
9
Matching for the D antigen in haematopoietic progenitor cell transplantation: definition and clinical outcomes.造血干细胞移植中D抗原的配型:定义及临床结果
Blood Transfus. 2014 Jul;12(3):301-6. doi: 10.2450/2014.0238-13. Epub 2014 Mar 19.
10
Implementation of a mandatory donor RHD screening in Switzerland.瑞士实施强制性献血者 RhD 血型筛查。
Transfus Apher Sci. 2014 Apr;50(2):169-74. doi: 10.1016/j.transci.2014.02.011. Epub 2014 Mar 6.